Position in FDMT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$793,185
+$289,505 QoQ
Shares Held
59,638
+10.2% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,298,250 across 329 Biotechnology names. FDMT ranks #153 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in FDMT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $793,185 | 59,638 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $503,680 | 54,101 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $403,837 | 53,845 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $557,715 | 64,179 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $244,704 | 65,958 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $228,693 | 70,803 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $409,010 | 73,431 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $754,062 | 69,756 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,530,863 | 72,933 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,034,930 | 63,871 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,213,999 | 59,921 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $744,055 | 58,449 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $885,213 | 48,988 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $816,542 | 47,501 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,053,709 | 47,443 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $364,798 | 45,373 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $290,263 | 41,585 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $530,666 | 35,097 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $673,887 | 30,715 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $661,789 | 24,538 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $228,928 | 9,507 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $254,033 | 5,856 | Shares | Sole | 2021-05-06 | |
| No filing history on record for this holder in this stock. | ||||||